Saturday, August 31, 2013

How Congress Encourages Shortages of Cancer Drugs

2011 and 2012 saw a quickening of interest in the deadly problem of acute shortages of injected drugs, especially those targeting cancer. Drugs defined as being in “short supply” by the Food and Drug Administration (FDA) increased from 61 in 2005 to more than 250 in 2011. Since reforms passed Congress thirteen months ago, the problem has gotten 20 percent worse.

The fundamental reason for Congress' failure is that it increased the power of the FDA, when it should have decreased it.

Read the entire article at The Apothecary.

No comments: